Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno Buecher

Showing results (21-30 of 115) with videos related to

Pageof 12
Sort By:
Diseases of the Colon and Rectum|August 4, 2007
Colorectal adenomatous polyposis Associated with MYH mutations: genotype and phenotype characteristicsGuillaume Bouguen, Sylvain Manfredi, Martine Blayau, et al.
International Journal of Molecular Sciences|September 22, 2020
Anti-Telomerase CD4<sup>+</sup> Th1 Immunity and Monocytic-Myeloid-Derived-Suppressor Cells Are Associated with Long-Term Efficacy Achieved by Docetaxel, Cisplatin, and 5-Fluorouracil (DCF) in Advanced Anal Squamous Cell Carcinoma: Translational Study of Epitopes-HPV01 and 02 TrialsLaurie Spehner, Stefano Kim, Angélique Vienot, et al.
Bulletin Du Cancer|November 27, 2025
[Upper-gastrointestinal tract toxicities associated with Immune Checkpoint Inhibitors (ICI)]Justine Vivier Chicoteau, Lucie Thibault, Pauline Vaflard, et al.
Reproduction, Nutrition, Development|February 20, 2004
Fructooligosaccharide associated with celecoxib reduces the number of aberrant crypt foci in the colon of ratsBruno Buecher, Cécile Thouminot, Jean Menanteau, et al.
Cancer Letters|May 25, 2005
The PPAR(gamma) K422Q mutation does not contribute to troglitazone inefficiency in colon cancer treatmentDelphine Bouancheau, Bruno Buecher, Anne Jarry, et al.
Familial Cancer|August 19, 2017
Sporadic endometrial adenocarcinoma with MMR deficiency due to biallelic MSH2 somatic mutationsBruno Buecher, Antoine De Pauw, Louis Bazire, et al.
World Journal of Gastroenterology|June 8, 2013
Early dynamic transcriptomic changes during preoperative radiotherapy in patients with rectal cancer: a feasibility studyStephane Supiot, Wilfried Gouraud, Loïc Campion, et al.
European Journal of Gastroenterology & Hepatology|February 10, 2011
Clinical impact of fluorodeoxyglucose-positron emission tomography scan/computed tomography in comparison with computed tomography on the detection of colorectal cancer recurrenceCéline Deleau, Bruno Buecher, Caroline Rousseau, et al.
International Journal of Cancer|July 4, 2017
HPV circulating tumor DNA to monitor the efficacy of anti-PD-1 therapy in metastatic squamous cell carcinoma of the anal canal: A case reportLuc Cabel, François-Clément Bidard, Vincent Servois, et al.
Anticancer Research|April 9, 2005
Growth inhibitory effect of celecoxib and rofecoxib on human colorectal carcinoma cell linesBruno Buecher, Delphine Bouancheau, Alexis Broquet, et al.
Pageof 12

Showing results (21-30 of 115) with videos related to

Sort By:
Pageof 12
Diseases of the Colon and Rectum|August 4, 2007
Colorectal adenomatous polyposis Associated with MYH mutations: genotype and phenotype characteristicsGuillaume Bouguen, Sylvain Manfredi, Martine Blayau, et al.
International Journal of Molecular Sciences|September 22, 2020
Anti-Telomerase CD4<sup>+</sup> Th1 Immunity and Monocytic-Myeloid-Derived-Suppressor Cells Are Associated with Long-Term Efficacy Achieved by Docetaxel, Cisplatin, and 5-Fluorouracil (DCF) in Advanced Anal Squamous Cell Carcinoma: Translational Study of Epitopes-HPV01 and 02 TrialsLaurie Spehner, Stefano Kim, Angélique Vienot, et al.
Bulletin Du Cancer|November 27, 2025
[Upper-gastrointestinal tract toxicities associated with Immune Checkpoint Inhibitors (ICI)]Justine Vivier Chicoteau, Lucie Thibault, Pauline Vaflard, et al.
Reproduction, Nutrition, Development|February 20, 2004
Fructooligosaccharide associated with celecoxib reduces the number of aberrant crypt foci in the colon of ratsBruno Buecher, Cécile Thouminot, Jean Menanteau, et al.
Cancer Letters|May 25, 2005
The PPAR(gamma) K422Q mutation does not contribute to troglitazone inefficiency in colon cancer treatmentDelphine Bouancheau, Bruno Buecher, Anne Jarry, et al.
Familial Cancer|August 19, 2017
Sporadic endometrial adenocarcinoma with MMR deficiency due to biallelic MSH2 somatic mutationsBruno Buecher, Antoine De Pauw, Louis Bazire, et al.
World Journal of Gastroenterology|June 8, 2013
Early dynamic transcriptomic changes during preoperative radiotherapy in patients with rectal cancer: a feasibility studyStephane Supiot, Wilfried Gouraud, Loïc Campion, et al.
European Journal of Gastroenterology & Hepatology|February 10, 2011
Clinical impact of fluorodeoxyglucose-positron emission tomography scan/computed tomography in comparison with computed tomography on the detection of colorectal cancer recurrenceCéline Deleau, Bruno Buecher, Caroline Rousseau, et al.
International Journal of Cancer|July 4, 2017
HPV circulating tumor DNA to monitor the efficacy of anti-PD-1 therapy in metastatic squamous cell carcinoma of the anal canal: A case reportLuc Cabel, François-Clément Bidard, Vincent Servois, et al.
Anticancer Research|April 9, 2005
Growth inhibitory effect of celecoxib and rofecoxib on human colorectal carcinoma cell linesBruno Buecher, Delphine Bouancheau, Alexis Broquet, et al.
Pageof 12